Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Comment by Uknowiton Oct 24, 2019 11:45pm
71 Views
Post# 30267770

RE:Another pump on this stock.

RE:Another pump on this stock.

Stil is now producing isolate from their Poland facility that will be used to meet their agreement with  Bioscience. The revenue will start coming in this quarter. October may be slow but by December they'll be at close to full output before December. Watch for the financials from this, the fourth quarter. And quit spreading lies about Romania. They'll be in operation later this year or at the very latest in the first quarter of 2020. I'll be back to show the financials for Q4 and Q1. 

They also had a bumper crop of hemp this year and I'm sure they'll announce total production soon.  Other extractors in Europe are in dire need of biomass to meet their obligations on the deals they have. Stil will be in a solid position for tolling agreements. They won't do anymore bulk hemp deals period. They're in the position to enter into lucrative agreements to this end. I also expect them to start pushing their neutraceutical lines in the US so as to avoid competition issues with Dragonfly in Europe. Revenues are coming and they'll be higher than most people expect. Mark my words and watch and wait. Buying Stil at the current share price is a no brainer. Cheers. 

<< Previous
Bullboard Posts
Next >>